Skip to main content


Archived Comments for: Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy

Back to article


    Andrea Savarino, ISS

    29 March 2010

    I am sorry I noticed the following errors in the published version of the manuscript:

    Additional file 1: Please erase from caption: “the highly conserved catalytic residues D64, D116 and E152 (presented in yellow) and”.

    Abstract: “Tenofovir disoproxil fumarate” should read, simply, "tenofovir".

    Background, fourth paragraph: Again, please do not consider “disoproxil fumarate”.

    Caption of Figure 2: Sixth line: Please do not consider “pro-drug”. Seventh line:“Tenofovir disoproxil fumarate” should read, simply, "tenofovir".

    Methods section "Nonhuman primate studies": “50 mg/kg/BID or 100 mg/kg/BID” Please do not consider “/kg/” thus it should read as: “50 mg BID or 100 mg BID”.

    Andrea Savarino, M.D.
    Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità,
    Viale Regina Elena, 299, 00161, Rome, Italy.

    Competing interests

    We have no competing interests.